Cargando…
SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation
Activation of RIPK1-driven cell death and inflammation play important roles in the progression of nonalcoholic steatohepatitis (NASH). However, the mechanism underlying RIPK1 activation in NASH remains unclear. Here we identified SENP1, a SUMO-specific protease, as a key endogenous inhibitor of RIPK...
Autores principales: | Yan, Lingjie, Zhang, Tao, Wang, Kai, Chen, Zezhao, Yang, Yuanxin, Shan, Bing, Sun, Qi, Zhang, Mengmeng, Zhang, Yichi, Zhong, Yedan, Liu, Nan, Gu, Jinyang, Xu, Daichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681887/ https://www.ncbi.nlm.nih.gov/pubmed/36414671 http://dx.doi.org/10.1038/s41467-022-34993-0 |
Ejemplares similares
-
UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
por: Zhang, Tao, et al.
Publicado: (2023) -
RIPK1 regulates starvation resistance by modulating aspartate catabolism
por: Mei, Xinyu, et al.
Publicado: (2021) -
Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
por: Geng, Jiefei, et al.
Publicado: (2017) -
NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis
por: Kondylis, Vangelis, et al.
Publicado: (2015) -
NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis
por: Kondylis, Vangelis, et al.
Publicado: (2015)